JCM
AHCO icon

JS Capital Management’s AdaptHealth AHCO Stock Holding History

JS Capital Management’s Portfolio AHCO Stock Details AHCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-13,700
Closed -$515K – 139
2020
Q4 		$515K Buy
+13,700
New +$424K 0.02% 85

Other funds holding AHCO

OCA
OEP Capital Advisors New York $194M AUM 9.78% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
SHI
SV Health Investors Boston, Massachusetts $32.3M AUM 20.15% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

JS Capital Management's AHCO Position: Q1 2021 in Review

JS Capital Management sold out of AdaptHealth (AHCO) in Q1 2021, closing a stake of 13,700 shares — an estimated $515K sold.

JS Capital Management first reported a position in AHCO in Q4 2020 and held it in 1 quarter. The position peaked at $515K in Q4 2020. 145 funds tracked by Wall St. Rank hold AHCO as of Q1 2021.

  • JS Capital Management reported no remaining AdaptHealth position as of Q1 2021 after selling out during the quarter.
  • JS Capital Management sold 13,700 AdaptHealth shares in Q1 2021, an estimated $515K.
  • JS Capital Management first reported a position in AdaptHealth in Q4 2020 and held it in 1 quarter.
  • JS Capital Management's AdaptHealth position peaked at $515K in Q4 2020.
  • 145 funds tracked by Wall St. Rank held AdaptHealth as of Q1 2021.

Based on JS Capital Management's 13F filing for Q1 2021, filed 17 May 2021.